University of California San Francisco
Give to UCSF
For New Patients with Paralysis, Tighter Blood Pressure Control Management May Lead to More Mobility
A man was paralyzed from the neck down in a surfing accident. Now he can walk again. Using machine learning, UCSF researchers found that controlling blood pressure during surgery may aid in patient recovery from spinal cord injuries.
Dual-Drug Therapy Shows Promise for Treating Alcohol Use Disorder
UCSF researchers have leveraged two new molecules, one of which is currently in clinical oncology trials, to devise a dual-drug therapy for alcohol use disorder (AUD), without the side effects or complications associated with current treatment regimens.
Scientists Find Mechanism that Eliminates Senescent Cells
Scientists at UCSF are learning how immune cells naturally clear the body of defunct – or senescent – cells that contribute to aging and many chronic diseases
Smart Cell Therapies for Solid Cancers Ready to Move Toward Clinical Trials
Researchers at UCSF have demonstrated how to engineer smart immune cells that are effective against solid tumors, opening the door to treating a variety of cancers that have long been untouchable with immunotherapies.
Probiotics: Health Hack or Hype?
We turned to UCSF scientists to better understand probiotics and the human microbiome they aim to influence.
Bioartificial Kidney Project Receives $1M Grant to Advance Its Work
The John and Marcia Goldman Foundation, a private family foundation based in San Francisco, recently granted The Kidney Project $1 million to advance its bioartificial kidney.
Urine Test Can Detect Likelihood of Kidney Transplant Rejection
A simple urine test can diagnose and predict acute rejection in kidney transplants, leading to an opportunity for earlier detection and treatment, according to a new study by researchers at UCSF.
Superfast Brain Circuit Slams the Brakes on Movement
A new UCSF study of patients with Parkinson’s disease has revealed a pathway that transmits signals very rapidly between two parts of the human brain to govern the complex act of halting a motion once it’s been initiated.
Old Drug Offers New Hope for Children with Devastating Disorder
A drug that once helped obese adults lose weight, but was withdrawn from the market due to heart risks, may be safe and effective for children with a life-threatening seizure disorder called Dravet syndrome.
Stem Cell Therapy: What’s Real and What’s Not at California’s For-Profit Clinics
We asked Arnold Kriegstein, MD, PhD, director of the UCSF Developmental & Stem Cell Biology Program, about for-profit stem cell clinics and what’s real and what’s not in stem cell medicine.
Gene Discovery Solves 51-Year-Old Clinical Mystery
The cause of the pancreatic inflammation plaguing a rural California family has been a medical mystery since it was first described 51 years ago. Now genetic sleuth-work by researchers from UC San Francisco and the University of Chicago has solved the mystery: pointing to a novel gene mutation as the cause of the family’s inherited pancreatitis.
NIH-Funded Research Consortium to Target Frontotemporal Lobar Degeneration
The National Institutes of Health has awarded a five-year, multi-investigator research grant expected to total more than $63 million to Mayo Clinic and UC San Francisco, to advance treatments for frontotemporal lobar degeneration.
